Altered mucosal bacteria and metabolomics in patients with Peutz-Jeghers syndrome

Author(s): Sui Wang[sup.2], Guan-Jun Kou[sup.1], Xiao-Han Zhao[sup.1], Gang Huang[sup.1], Jue-Xin Wang[sup.1], Lin Tian[sup.1], Xiu-Li Zuo[sup.1], Yan-Qing Li[sup.1], Jia-Yong Wang[sup.3] and Yan-Bo Yu[sup.1] Introduction Peutz-Jeghers syndrome (PJS) is a rare genetic [...]
Background Peutz-Jeghers syndrome (PJS) is a rare genetic disorder characterized by the development of pigmented spots, gastrointestinal polyps and increased susceptibility to cancers. Currently, most studies have investigated intestinal microbiota through fecal microbiota, and there are few reports about mucosa-associated microbiota. It remains valuable to search for the key intestinal microbiota or abnormal metabolic pathways linked to PJS. Aim This study aimed to assess the structure and composition of mucosa-associated microbiota in patients with PJS and to explore the potential influence of intestinal microbiota disorders and metabolite changes on PJS. Methods The bacterial composition was analyzed in 13 PJS patients and 12 controls using 16S rRNA gene sequencing (Illumina MiSeq) for bacteria. Differential analyses of the intestinal microbiota were performed from the phylum to species level. Liquid chromatography-tandem mass spectrometry (LC-MS) was used to detect the differentially abundant metabolites of PJS patients and controls to identify different metabolites and metabolic biomarkers of small intestinal mucosa samples. Results High-throughput sequencing confirmed the special characteristics and biodiversity of the mucosa microflora in patients with PJS. They had lower bacterial biodiversity than controls. The abundance of intestinal mucosal microflora was significantly lower than that of fecal microflora. In addition, lipid metabolism, amino acid metabolism, carbohydrate metabolism, nucleotide metabolism and other pathways were significantly different from those of controls, which were associated with the development of the enteric nervous system, intestinal inflammation and development of tumors. Conclusion This is the first report on the mucosa-associated microbiota and metabolite profile of subjects with PJS, which may be meaningful to provide a structural basis for further research on intestinal microecology in PJS. Keywords: Peutz-Jeghers syndrome, Metabolomics, LC-MS, Mucosa-associated microbiota, Bacteria